Home / Knowledge / News / Textiles / Crosstex' new BIOSAFE-treated facemasks against H1N1 influenza
Crosstex' new BIOSAFE-treated facemasks against H1N1 influenza
14
Oct '09
BIOSAFE Inc, a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE. Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.

Gary Steinberg, CEO of Crosstex, stated, "Facemasks serve as the first line of defense against airborne particles by trapping them in the filter media. However, live microorganisms can continue to live on the mask surface. Our new BIOSAFE treated Ultra Sensitive facemasks enhance the functionality of the mask by actually killing the harmful microorganisms, reducing the cross-contamination risk from touching the mask itself, and creating a safer environment upon disposal of the mask."

"The BIOSAFE treatment additive, as approved by the EPA, was compatible with our manufacturing process. We were attracted to the product since it chemically binds to the outer mask surface creating a long-lasting shield against microbial contamination and, because BIOSAFE mechanically kills cells, therefore will not cause development of more resistant 'superbugs'."

Max Fedor, President and CEO of BIOSAFE declared, "In the simplest terms, BIOSAFE's HM4100 is better, faster, and less costly as an antimicrobial additive. It provides protection for the life of the product and because of the way it works it does not promote adaptive organisms or 'superbugs'. Our product's safety is unparalleled and it has passed all required toxicity tests and received an EPA label. It has also passed USP / ISO biocompatibility tests that are normally required for medical device materials."

He continued, "The worldwide market for antimicrobials is $6 billion and some of the solutions historically deployed need to be upgraded to improved science such as BIOSAFE's. Our product is non-leaching, has no volatile organic compounds (VOCs), heavy metals, or polychlorinated phenols. We provide significant benefits in manufacturability thereby reducing hurdles to adoption, while lowering the ultimate costs in the process."

Cantel's President and CEO, Andrew Krakauer explained, "BIOSAFE is an important component of our strategic plans to expand our liquid chemical germicide business and invest more aggressively in research & development. Given the unique performance, manufacturability, and cost advantages of this additive, Cantel has embarked on a number of internal R&D initiatives to incorporate BIOSAFE into a variety of its other products." Mr. Krakauer continued, "We have invested significant dollars, resources, and time towards this goal and it has been a fantastic cross-divisional effort that demonstrates how we are gaining leverage from the expertise in our different companies."

Within the United States, the sale of facemasks treated with BIOSAFE antimicrobial for medical applications is subject to a 510(k) clearance by the U.S. Food and Drug Administration. At this time the Company is awaiting publication of the latest revision of the FDA Guidance Document pertaining to antimicrobial treatments of medical devices prior to the filing of its application. The Company is in the process of submitting an application with the U.S. Environmental Protection Agency covering the sale of treated masks in the United States for non-medical applications.

Must ReadView All

Textiles | On 10th Dec 2016

India’s 2016-17 cotton import to touch 17 lakh bales

The import of cotton from international markets by spinning mills in...

Textiles | On 10th Dec 2016

US textile & apparel imports fall 6.50% in Jan-Oct ’16

The import of textiles and apparel by United States dropped 6.50 per...

Unipar Carbocloro plant in the city of Cubatão, São Paulo state. Courtesy: Wikipedia

Textiles | On 10th Dec 2016

Brazil’s CADE clears Solvay’s 70.59% stake sale in Indupa

Brazil’s administrative council for economic defence (CADE) has...

Interviews View All

Priyanka
Studio Priyanka Rajiv

‘To reinvent the age-old tradition of embroidery to suit demographics and...

Janak Dhamanwala & Sunil Dhamanwala
Jansun

Moving towards sustainability is also a social change

Ajay Ghariwala
Luthra Group

We are ready to adopt or follow every opportunity

Kevin Nelson
TissueGen

Kevin Nelson, Chief Scientific Officer, TissueGen discusses the growing...

Eamonn Tighe
Nature Works LLC

Eamonn Tighe, Fibres and Nonwovens - Business Development Manager of...

Giorgio Mantovani
Corman S.p.A

Giorgio Mantovani, MD of Corman, with a presence in both Milano and New...

Ritu Kumar
Label Ritu Kumar

‘Classics will return’ "There are a lot of people wearing western clothes ...

Rupa Sood and Sharan Apparao
Nayaab

Nayaab, an exhibition meant to celebrate Indian weaves, is in its second...

Silvia Venturini Fendi
Fendi s.r.l

"Yes, my confidence and positive attitude are my strengths and should be...

Press Release

Press Release

Letter to Editor

Letter to Editor

RSS Feed

RSS Feed

Submit your press release on


editorial@fibre2fashion.com

Letter To Editor






(Max. 8000 char.)

Search Companies





SEARCH
December 2016

December 2016

Subscribe today and get the latest update on Textiles, Fashion, Apparel and so on.

SUBSCRIBE


Browse Our Archives

GO


Advanced Search